INNOVATE BIOPHARMACEUTICALS, INC. Purchase Agreements
9 Contracts & Agreements
- Form of Securities Purchase Agreement (Filed With SEC on March 15, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on June 30, 2022)
- Asset Purchase Agreement between 9 Meters Biopharma, Inc. and Lobesity, LLC, dated July 19, 2021 (Filed With SEC on November 15, 2021)
- Securities Purchase Agreement, dated April 29, 2020, between Innovate Biopharmaceuticals, Inc. and the investors named therein (Filed With SEC on May 4, 2020)
- Form of Securities Purchase Agreement, dated April 29, 2019, by and among the Company and the purchasers party thereto (Filed With SEC on May 1, 2019)
- Amendment, dated April 25, 2019, to Securities Purchase Agreement, dated as of March 17, 2019, by and between the Company and the Purchasers party thereto (Filed With SEC on April 26, 2019)
- Asset Purchase Agreement, dated December 23, 2014, between Innovate Biopharmaceuticals Inc. (now IB Pharmaceuticals Inc.) and Repligen Corporation (Filed With SEC on March 14, 2018)
- UNIT PURCHASE OPTION FOR THE PURCHASE OF [•] UNITS OF SECURITIES OF MONSTER DIGITAL, INC. (Filed With SEC on June 9, 2016)
- PURCHASE ORDER PURCHASE AGREEMENT (Filed With SEC on November 10, 2015)